Swedbank AB Has $88.03 Million Stake in The Cooper Companies, Inc. $COO

Swedbank AB increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 18.8% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,074,029 shares of the medical device company’s stock after purchasing an additional 170,000 shares during the quarter. Swedbank AB owned approximately 0.55% of Cooper Companies worth $88,027,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bell Investment Advisors Inc lifted its holdings in Cooper Companies by 106.3% in the 3rd quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after purchasing an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new stake in Cooper Companies in the 2nd quarter worth approximately $36,000. True Wealth Design LLC lifted its holdings in Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the last quarter. Cromwell Holdings LLC lifted its holdings in Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after purchasing an additional 273 shares during the last quarter. Finally, Board of the Pension Protection Fund acquired a new stake in Cooper Companies in the 4th quarter worth approximately $41,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Needham & Company LLC boosted their target price on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, March 6th. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 target price for the company. in a report on Wednesday, March 4th. Barclays boosted their target price on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. Finally, William Blair upgraded Cooper Companies to a “strong-buy” rating in a report on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Stock Down 0.5%

Shares of COO stock opened at $62.55 on Friday. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The firm has a market cap of $12.20 billion, a PE ratio of 30.97, a price-to-earnings-growth ratio of 1.61 and a beta of 0.89. The stock has a 50 day moving average of $66.92 and a 200-day moving average of $75.14. The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the company earned $0.92 earnings per share. The company’s quarterly revenue was up 6.2% compared to the same quarter last year. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, equities analysts predict that The Cooper Companies, Inc. will post 4.62 EPS for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.